Identification of the transcription factor ZEB1 as a central component of the adipogenic gene regulatory network

  1. Carine Gubelmann
  2. Petra C Schwalie
  3. Sunil K Raghav
  4. Eva Röder
  5. Tenagne Delessa
  6. Elke Kiehlmann
  7. Sebastian M Waszak
  8. Andrea Corsinotti
  9. Gilles Udin
  10. Wiebke Holcombe
  11. Gottfried Rudofsky
  12. Didier Trono
  13. Christian Wolfrum
  14. Bart Deplancke  Is a corresponding author
  1. Ecole Polytechnique Fédérale de Lausanne, Switzerland
  2. Institute of Life Sciences, India
  3. ETH Zürich, Switzerland
  4. European Molecular Biology Laboratory, Germany
  5. University of Edinburgh, Scotland
  6. Diabetologie und Klinische Ernährung Kantonsspital Olten, Switzerland

Abstract

Adipose tissue is a key determinant of whole body metabolism and energy homeostasis. Unraveling the regulatory mechanisms underlying adipogenesis is therefore highly relevant from a biomedical perspective. Our current understanding of fat cell differentiation is centered on the transcriptional cascades driven by the C/EBP protein family and the master regulator PPARγ. To elucidate further components of the adipogenic gene regulatory network, we performed a large-scale transcription factor (TF) screen overexpressing 734 TFs in mouse pre-adipocytes and probed their effect on differentiation. We identified 23 novel pro-adipogenic TFs and characterized the top ranking TF, ZEB1, as being essential for adipogenesis both in vitro and in vivo. Moreover, its expression levels correlate with fat cell differentiation potential in humans. Genomic profiling further revealed that this TF directly targets and controls the expression of most early and late adipogenic regulators, identifying ZEB1 as a central transcriptional component of fat cell differentiation.

Article and author information

Author details

  1. Carine Gubelmann

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  2. Petra C Schwalie

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Sunil K Raghav

    Institute of Life Sciences, Bhubaneswar, India
    Competing interests
    The authors declare that no competing interests exist.
  4. Eva Röder

    ETH Zürich, Schwerzenbach, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Tenagne Delessa

    ETH Zürich, Schwerzenbach, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  6. Elke Kiehlmann

    ETH Zürich, Schwerzenbach, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  7. Sebastian M Waszak

    European Molecular Biology Laboratory, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Andrea Corsinotti

    University of Edinburgh, Edinburgh, Scotland
    Competing interests
    The authors declare that no competing interests exist.
  9. Gilles Udin

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  10. Wiebke Holcombe

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  11. Gottfried Rudofsky

    Diabetologie und Klinische Ernährung Kantonsspital Olten, Olten, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  12. Didier Trono

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  13. Christian Wolfrum

    ETH Zürich, Schwerzenbach, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Bart Deplancke

    Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
    For correspondence
    bart.deplancke@epfl.ch
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: All animal experiments were conducted in strict accordance with Swiss law and all experiments were approved by the ethics commission of the state veterinary office (60/2012, 43/2011).

Human subjects: The work on obese subjects was approved by the ethics committee at the University Hospital of Heidelberg and is conforming to the ethical guidelines of the 2000 Helsinki declaration. All participants provided witnessed written informed consent prior entering the study (S-365/2007). The trial was registered as NCT00773565.

Copyright

© 2014, Gubelmann et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,533
    views
  • 825
    downloads
  • 88
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carine Gubelmann
  2. Petra C Schwalie
  3. Sunil K Raghav
  4. Eva Röder
  5. Tenagne Delessa
  6. Elke Kiehlmann
  7. Sebastian M Waszak
  8. Andrea Corsinotti
  9. Gilles Udin
  10. Wiebke Holcombe
  11. Gottfried Rudofsky
  12. Didier Trono
  13. Christian Wolfrum
  14. Bart Deplancke
(2014)
Identification of the transcription factor ZEB1 as a central component of the adipogenic gene regulatory network
eLife 3:e03346.
https://doi.org/10.7554/eLife.03346

Share this article

https://doi.org/10.7554/eLife.03346

Further reading

    1. Developmental Biology
    Saira Amir, Olatunbosun Arowolo ... Alexander Suvorov
    Research Article

    Over the past several decades, a trend toward delayed childbirth has led to increases in parental age at the time of conception. Sperm epigenome undergoes age-dependent changes increasing risks of adverse conditions in offspring conceived by fathers of advanced age. The mechanism(s) linking paternal age with epigenetic changes in sperm remain unknown. The sperm epigenome is shaped in a compartment protected by the blood-testes barrier (BTB) known to deteriorate with age. Permeability of the BTB is regulated by the balance of two mTOR complexes in Sertoli cells where mTOR complex 1 (mTORC1) promotes the opening of the BTB and mTOR complex 2 (mTORC2) promotes its integrity. We hypothesized that this balance is also responsible for age-dependent changes in the sperm epigenome. To test this hypothesis, we analyzed reproductive outcomes, including sperm DNA methylation in transgenic mice with Sertoli cell-specific suppression of mTORC1 (Rptor KO) or mTORC2 (Rictor KO). mTORC2 suppression accelerated aging of the sperm DNA methylome and resulted in a reproductive phenotype concordant with older age, including decreased testes weight and sperm counts, and increased percent of morphologically abnormal spermatozoa and mitochondrial DNA copy number. Suppression of mTORC1 resulted in the shift of DNA methylome in sperm opposite to the shift associated with physiological aging – sperm DNA methylome rejuvenation and mild changes in sperm parameters. These results demonstrate for the first time that the balance of mTOR complexes in Sertoli cells regulates the rate of sperm epigenetic aging. Thus, mTOR pathway in Sertoli cells may be used as a novel target of therapeutic interventions to rejuvenate the sperm epigenome in advanced-age fathers.

    1. Developmental Biology
    Jing Wang, Yingying Yin ... Zhaojian Liu
    Research Article

    Transmembrane channel-like (TMC) proteins are a highly conserved ion channel family consisting of eight members (TMC1–TMC8) in mammals. TMC1/2 are components of the mechanotransduction channel in hair cells, and mutations of TMC1/2 cause deafness in humans and mice. However, the physiological roles of other TMC proteins remain largely unknown. Here, we show that Tmc7 is specifically expressed in the testis and that it is required for acrosome biogenesis during spermatogenesis. Tmc7−/− mice exhibited abnormal sperm head, disorganized mitochondrial sheaths, and reduced number of elongating spermatids, similar to human oligo-astheno-teratozoospermia. We further demonstrate that TMC7 is colocalized with GM130 at the cis-Golgi region in round spermatids. TMC7 deficiency leads to aberrant Golgi morphology and impaired fusion of Golgi-derived vesicles to the developing acrosome. Moreover, upon loss of TMC7 intracellular ion homeostasis is impaired and ROS levels are increased, which in turn causes Golgi and endoplasmic reticulum stress. Taken together, these results suggest that TMC7 is required to maintain pH and ion homeostasis, which is needed for acrosome biogenesis. Our findings unveil a novel role for TMC7 in acrosome biogenesis during spermiogenesis.